Leishmaniasis: Pathophysiology & Treatment - Dr. John Bartlett

Loading...

From the course by Duke University

Tropical Parasitology: Protozoans, Worms, Vectors and Human Diseases

141 ratings

Duke University

Tropical Parasitology: Protozoans, Worms, Vectors and Human Diseases

141 ratings

This course provides students an understanding of important human parasitic diseases, including their life cycles, vectors of transmission, distribution and epidemiology, pathophysiology and clinical manifestations, treatment, and prevention and control. Tropical Parasitology is taught by faculty from an area highly impacted by tropical parasites- the Kilimanjaro Christian Medical University College in Moshi, Tanzania. The faculty include Drs. Frank Mosha and Mramba Nyindo (and two lecturers, Drs. Johnson Matowo and Jovin Kitau). Dr. John Bartlett, Professor of Medicine, Global Health and Nursing at Duke University, joins his faculty colleagues in this effort.

From the lesson

Protozoans

Leishmaniasis: Parasites and Vectors - Dr. Mramba Nyindo13:53

Leishmaniasis: Pathophysiology & Treatment - Dr. John Bartlett6:08

Meet the Instructors

John A. Bartlett, M.D.
Professor of Medicine, Global Health and Nursing at Duke University Medical Center
Duke Global Health Institute
Franklin Mosha, Ph.D.
Professor of Parasitology and Medical Entomology
Mramba Nyindo, Ph.D.
Associate Professor, Kilimanjaro Christian Medical University College (KCMU Co.)

Let us now talk about a fascinating disease Leishmaniasis.

Let's review its pathophysiology, clinical manifestations, and treatment.

Leishmania multiplies in cells of the mononuclear phagocyte system.

Such as monocytes, macrophages, histiocytes,

Kupffer cells, and reticuloendothelial cells in the liver and spleen.

Following a sandfly bite, the skin is inoculated with promastigotes.

They are phagocytized, mature into amastigotes, and multiply intracellularly.

At this point the infection may be eradicated in some hosts, and

they may become immune to reinfection with this Leishmania species.

In other patients, the infection disseminates hematogenously to multiple

organs in a process known as visceral Leishmaniasis.

A local cutaneous infection may occur at the inoculation site.

Vigorous local inflammatory responses may follow.

In some persons the lesion heals spontaneously.

In others, a chronic localized infection develops which is disfiguring.

In others, the infection spreads to adjacent mucosal surfaces.

Post-Kala Azar dermal Leishmaniasis or

diffuse cutaneous Leishmaniasis may occur.

In some hosts dissemination occurs throughout the mononuclear

phagocyte system in multiple organs including the spleen,

liver, bone marrow and lymphoid tissue.

These organs may demonstrate organisms within macrophages and

granulomatous inflammation.

Chronic diseases which cause immune compromise may predispose to

dissemination such as HIV infection and malnutrition.

Cutaneous lesions have an incubation period of 1 week to 2 months.

Typically they begin as an ulceration, and

may resolve spontaneously or progressively worsen.

Here we see a Leishmanian skin ulcer.

Note the clean ulceration base, the raised edge and the surrounding erythema.

For visceral Leishmania, the incubation period may be 3 weeks to 2 years,

although it's usually 2 to 4 months.

Symptoms may include fever, malaise, fatigue,

headache, abdominal pain, anorexia and diarrhea.

Acutely skin lesions may appear as an ulcer and drain.

They may occur anywhere but are most commonly seen on limbs.

Chronic skin lesions due to leishmania may have very diverse appearances.

Clinical suspicion and biopsy are essential to establish the diagnosis.

In visceral Leishmaniasis, spenomegaly is nearly universal and may be massive.

Hepatomegaly is also common.

Severe disease may include emaciation and marked abdominal distention.

Severe disease may be further complicated by intercurrent infections such as

pneumonia, sepsis, TB, brucellosis and dysentery.

In visceral Leishmaniasis there my be hypergammaglobulinemia and

hypoalbuminemia.

Liver enzymes are commonly elevated.

Pancytopenia is very common.

Diagnosis is made by demonstration of the organism,

which can commonly be done through splenic puncture, liver or bone marrow biopsy,

lymph node aspiration, or staining of peripheral blood buffy coat.

In terms of treatment, skin lesions may heal spontaneously and

may not need treatment.

Individualized treatment decisions are needed depending on the host

risk of dissemination, severity of the skin lesion and

risk of permanent disfigurement due to scarring.

Options for treatment of skin lesions include topical therapy or

systemic therapy.

Visceral Leishmaniasis requires systemic treatment.

Choices for systemic treatment should consider the infecting species

of Leishmania, availability of medications, and the severity of disease.

The most commonly utilized medication is the pentavalent

antimonial compound stibogluconate.

Alternative options can include liposomal amphotericin B,

pentamidine, anoles and miltefosene.

Now let's consider a Case History.

A 14 year old boy presented with wasting and abdominal distention.

On exam he had a massive hepatosplenomegaly.

CBC showed pancytopenia,

a splenic puncture was performed and revealed Leishmania organisms.

Treatment was initiated with stibogluconate and he recovered well.

Explore our Catalog

Join for free and get personalized recommendations, updates and offers.

Coursera provides universal access to the world’s best education, partnering with top universities and organizations to offer courses online.

© 2018 Coursera Inc. All rights reserved.

Download on the App Store

Get it on Google Play